Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
75 hedge funds and large institutions have $116M invested in Ampio Pharmaceuticals Inc. in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 13 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 15
25% more capital invested
Capital invested by funds: $92.8M → $116M (+$23.4M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 78 → 75 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
40% less call options, than puts
Call options by funds: $3.4M | Put options by funds: $5.67M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Guild Investment Management
Los Angeles,
California
|
+$714K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$592K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$306K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$263K |
| 5 |
Bank of New York Mellon
New York
|
+$255K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.53M |
| 2 |
GCM
Goldman Capital Management
New York
|
-$1.28M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.24M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$796K |
| 5 |
D.E. Shaw & Co
New York
|
-$782K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCM
76
Goldman Capital Management
New York
| – | -$1.28M | -700 | Closed |
|
|
77
Alyeska Investment Group
Chicago,
Illinois
| – | -$1.24M | -650 | Closed |
|
|
LCM
78
Laurion Capital Management
New York
| – | -$796K | -418 | Closed |
|
|
UOC
79
UBS O'Connor
Chicago,
Illinois
| – | -$476K | -250 | Closed |
|
80
Goldman Sachs
New York
| – | -$237K | -124 | Closed |
|
|
PCM
81
Piermont Capital Management
St. Louis,
Missouri
| – | -$203K | -107 | Closed |
|
|
HCM
82
Highbridge Capital Management
New York
| – | -$202K | -106 | Closed |
|
83
SG Americas Securities
New York
| – | -$135K | -71 | Closed |
|
|
NI
84
Numeric Investors
Boston,
Massachusetts
| – | -$116K | -61 | Closed |
|
85
Principal Financial Group
Des Moines,
Iowa
| – | -$100K | -52 | Closed |
|
|
OAM
86
Oxford Asset Management
Oxford,
United Kingdom
| – | -$65K | -34 | Closed |
|
|
QT
87
Quantbot Technologies
New York
| – | -$43K | -23 | Closed |
|
|
CP
88
Corbenic Partners
Bethlehem,
Pennsylvania
| – | -$6K | -3 | Closed |
|
AMPE Hedge Fund Activity: Q2 2014 in Review
75 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2014, worth a combined $116M — up 25% from $92.8M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of AMPE and 10 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 35 added.
The largest buyer was Guild Investment Management, adding an estimated $714K. The largest seller was DAFNA Capital Management, cutting an estimated $1.53M.
- 75 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2014, down from 78 in Q1 2014.
- Funds reported $116M of Ampio Pharmaceuticals Inc. stock for Q2 2014, up 25% quarter-over-quarter.
- 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2014 and 13 closed out, a net change of -3 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2014 was Guild Investment Management, an estimated $714K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2014 was DAFNA Capital Management, an estimated $1.53M sold.
Based on aggregated 13F filings for Q2 2014.